International Progressive MS Alliance
Worldwide, more than 2.8 million people live with MS. More than half, over 1 million people, live with a progressive form of MS.
Progressive multiple sclerosis is a form of MS that gets worse over time. Each day, progressive MS takes things away from people: vision, mobility, cognition, ability to work, and their very independence.
Ending progressive multiple sclerosis (MS) is an urgent and unmet worldwide need. People living with this often debilitating form of MS face uncertainty, losing ground each day as they experience steadily worsening symptoms and a loss of myriad functions, which can cause a sense of helplessness. Recently, there has been scientific progress with the emergence of the very first potential therapies for progressive disease, but they will be effective only for some. More must be done so that EVERYONE has an effective treatment available.
An unprecedented global effort
MS Research Australia has joined the International Progressive MS Alliance, an unprecedented global collaboration of MS organisations, researchers, clinicians, pharmaceutical companies, and people with progressive MS, to transform the landscape of multiple sclerosis.
The International Progressive MS Alliance is ensuring that more will be done, fueling awareness, understanding and research collaboration. They are rallying the global community to come together and find solutions.
Remaining focused on our priorities will enable new treatment discovery while reducing the time and cost of testing potential treatments. This, in turn, will accelerate access to treatment for people with progressive MS.
People with the progressive disease now have hope for the future.
The Alliance is driving progress in three important ways
The International Progressive MS Alliance continues to grow and expand. The members of the Alliance fund the research and drive the work of the Alliance including fundraising, research, communications etc.